IP Library Granted Patent US 10,228,381
Granted Patent B2
US 10,228,381 · App. 15/648,085 · Granted Mar 12, 2019

Additive channels

Inventors: Daniel Levner (Brookline, MA); Christopher David Hinojosa (Cambridge, MA); Norman Wen (West Roxbury, MA); Jacob Fraser (Somerville, MA); Justin Nguyen (Medford, MA); Riccardo Barrile (Boston, MA); Geraldine Hamilton (Boston, MA); Catherine Karalis (Brookline, MA); Hyoungshin Park (Newton, MA); Antonio Varone (West Roxbury, MA); Andries Van der Meer (Enchede, NL); Monicah Otieno (Robbinville, NJ); David Conegliano (Boston, MA)
Assignee: EMULATE, Inc.
G01N33/86B01L3/5023B01L3/502707B01L3/502715B01L3/502746B01L3/502761C12M23/16C12M29/00C12M29/04C12M29/10C12M35/08C12M41/46G01N33/54366B01L2200/02B01L2200/027B01L2200/0605B01L2200/0647B01L2200/16B01L2300/0809B01L2300/0816B01L2300/0867B01L2300/0883B01L2300/0887B01L2300/14B01L2300/16G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,228,381
App. No.
15/648,085
Granted
Mar 12, 2019
Kind
B2
Abstract

Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

Claims (50)

1. A microfluidic device, comprising:

an input port;

an output port;

a test channel, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port;

endothelial cells disposed within at least one portion of said test channel; and

an input additive channel, wherein said input additive channel is in fluidic communication with said input portion of said test channel, and wherein said input additive channel is configured to deliver fluid to at least two opposing sides of said input portion of said test channel.

2. The device of claim 1 , wherein said endothelial cells are living.

3. The device of claim 1 , wherein said endothelial cells are fixed.

4. The device of claim 1 , wherein said input additive channel is configured to deliver fluid to at least two opposing sides of said input portion at or near said input port.

5. The device of claim 1 wherein said input additive channel divides into two or more additive channel branches, wherein said two or more additive channel branches are configured to produce an approximately equal fluidic resistance.

6. The device of claim 1 , further comprising an output additive channel in fluidic communication with said output portion of said test channel.

7. The device of claim 1 , further comprising a porous membrane and a back channel, wherein said membrane is situated between at least one portion of said test channel and at least one portion of said back channel.

8. The device of claim 7 , wherein at least one non-endothelial cell type is disposed within at least one portion of said back channel.

9. The device of claim 1 , wherein said input additive channel further comprises a fluidic resistor.

10. The device of claim 6 , wherein said output additive channel further comprises a fluidic resistor.

11. A microfluidic device, comprising:

an input port;

an output port;

a test channel, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port;

endothelial cells disposed within at least one portion of said test channel; and

an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel, and wherein said output additive channel is configured to deliver fluid to at least two opposing sides of said output portion of said test channel.

12. The device of claim 11 , wherein said endothelial cells are living.

13. The device of claim 11 , wherein said endothelial cells are fixed.

14. The device of claim 11 , wherein said output additive channel is configured to deliver fluid to at least two opposing sides of said output portion at or near said output port.

15. The device of claim 11 , wherein said output additive channel divides into two or more additive channel branches, wherein said two or more additive channel branches are configured to produce an approximately equal fluidic resistance.

16. The device of claim 11 , further comprising an input additive channel in fluidic communication with said input portion of said test channel.

17. The device of claim 11 , further comprising a porous membrane and a back channel, wherein said membrane is situated between at least one portion of said test channel and at least one portion of said back channel.

18. The device of claim 17 , wherein at least one non-endothelial cell type is disposed within at least one portion of said back channel.

19. The device of claim 11 , wherein said output additive channel further comprises a fluidic resistor.

20. The device of claim 16 , wherein said input additive channel further comprises a fluidic resistor.

21. A microfluidic device, comprising:

an input port;

an output port;

a test channel comprising surfaces, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port;

endothelial cells disposed within said test channel and covering all of said surfaces of said test channel so as to make a lumen;

an input additive channel, wherein said input additive channel is in fluidic communication with said input portion of said test channel.

22. The device of claim 21 , wherein said endothelial cells are living.

23. The device of claim 21 , further comprising an output additive channel in fluidic communication with said output portion of said test channel.

24. The device of claim 21 , further comprising an input channel in fluidic communication with said input portion of said test channel.

25. The device of claim 21 , further comprising and output channel in fluidic communication with output portion of said test channel.

26. A microfluidic device, comprising:

an input port;

an output port;

a test channel comprising surfaces, wherein said test channel comprises an input portion in fluidic communication with said input port and an output portion in fluidic communication with said output port;

endothelial cells disposed within said test channel and covering all of said surfaces of said test channel so as to make a lumen; and

an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel.

27. The device of claim 24 , wherein said endothelial cells are living.

28. The device of claim 24 , further comprising an input additive channel in fluidic communication with said input portion of said test channel.

29. The device of claim 26 , further comprising an input channel in fluidic communication with said input portion of said test channel.

30. The device of claim 26 , further comprising and output channel in fluidic communication with output portion of said test channel.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2020
From: JANSSEN BIOTECH, INC.
To: EMULATE, INC.
Reel/Frame 054150/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2018
From: LEVNER, DANIEL; HINOJOSA, CHRISTOPHER DAVID; WEN, NORMAN; FRASER, JACOB; NGUYEN, JUSTIN; BARRILE, RICCARDO; HAMILTON, GERALDINE; KARALIS, CATHERINE; PARK, HYOUNG SHIN; VARONE, ANTONIO; VAN DER MEER, ANDRIES; OTIENO, MONICAH; CONEGLIANO, DAVID
To: EMULATE, INC.; JANSSEN BIOTECH, INC.
Reel/Frame 045985/0453 →
Continuity (2)
Provisional Application 62361274 · Jul 12, 2016
Related Publication 20180015462A1 · Jan 18, 2018